Psoriasis induced by cetuximab: A paradoxical adverse effect
- 16 August 2010
- journal article
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 52 (1) , 56-58
Abstract
Cetuximab, an epidermal growth factor receptor inhibitor, is a chemotherapeutical agent featuring well‐known adverse dermatological effects related to tumour‐response prognosis. In psoriasis, the epidermal growth factor receptor is overexpressed; hence, the expectation would be that an epidermal growth factor receptor inhibitor could improve psoriatic lesions. We report a case of psoriasis induced by cetuximab, which was a surprising adverse effect.Keywords
This publication has 11 references indexed in Scilit:
- EGFR Regulates the Expression of Keratinocyte-Derived Granulocyte/Macrophage Colony-Stimulating Factor In Vitro and In VivoJournal of Investigative Dermatology, 2010
- Cetuximab Treatment in a Patient with Metastatic Colorectal Cancer and PsoriasisCurrent Oncology, 2008
- Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of actionArthritis Care & Research, 2008
- New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinraBritish Journal of Dermatology, 2008
- Incidence and management of cutaneous toxicities associated with cetuximabExpert Opinion on Drug Safety, 2007
- Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?British Journal of Dermatology, 2006
- Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapyActa Oncologica, 2004
- Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin InflammationThe American Journal of Pathology, 2003
- Inhibitors of Tyrosine Kinases in the Treatment of PsoriasisCurrent Pharmaceutical Design, 2000
- Epidermal Growth Factor/Transforming Growth Factor Alpha Receptors and PsoriasisJournal of Investigative Dermatology, 1990